PentaBind

PentaBind is a TechBio company using generative AI to design aptamers with drug-like properties for targets that are inaccessible to conventional modalities.

Its platform combines proprietary datasets with wet-laboratory validation to deliver multi-attribute aptamer candidates in a fraction of the time and cost of traditional SELEX methods.

The company focuses on oncology applications, including aptamer-drug conjugates, and offers AI-based aptamer design services to pharma and biotech partners.